Criteria
Leader criteria
Sector
Communication Services
80
Consumer Discretionary
292
Consumer Staples
106
Energy
122
Financials
467
Health Care
446
Industrials
477
Information Technology
431
Materials
223
Real Estate
119
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | Health Care | $20.00 | up 14.5% | up 17.6% | up 32.1% | 3.6% | 79 | 7/8 | $7.1B | — | — | down 6% | 1.1× | 0.78 | — | — | Elevated | |
| BLLN | Billiontoone, Inc. | Health Care | $113.32 | up 5.1% | up 6.5% | — | 5.1% | — | — | — | — | — | up 2% | — | 0.12 | — | — | Low | |
| BLSM | Blossomhill Therapeutics, Inc. | Health Care | $13.75 | down 6.0% | down 26.2% | — | 12.5% | — | — | — | — | — | — | — | — | — | — | Unknown | |
| BMRN | Biomarin Pharmaceutical Inc | Health Care | $58.51 | up 4.6% | down 2.5% | up 12.7% | 2.7% | 51 | 4/8 | $11.3B | 32.2× | — | up 6% | 1.8× | 0.10 | down 81% | 5/9 | Low | |
| BMY | Bristol Myers Squibb Co | Health Care | $62.48 | up 1.6% | up 1.2% | up 41.6% | 2.8% | 69 | 7/8 | $181.2B | 25.7× | — | up 41% | 9.8× | 2.32 | down 2% | 9/9 | Moderate | |
| BRKR | Bruker Corp | Health Care | $57.07 | down 0.9% | down 11.9% | up 57.3% | 5.4% | 79 | 7/8 | $8.7B | — | — | 0% | 3.5× | 0.75 | down 782% | 4/9 | Moderate | |
| BRVE | Braveheart Bio, Inc. | Health Care | $21.51 | up 0.3% | up 6.5% | — | 7.1% | — | — | — | — | — | — | — | — | — | — | Unknown | |
| BSX | Boston Scientific Corp | Health Care | $41.98 | down 8.1% | down 3.8% | down 58.3% | 3.6% | 7 | 0/8 | $73.3B | 25.3× | 0.45 | up 13% | 3.0× | 0.46 | up 15% | 8/9 | Low | |
| BTSG | Brightspring Health Services, Inc. | Health Care | $66.89 | up 11.3% | up 17.9% | up 104.0% | 3.8% | 91 | 8/8 | $12.9B | 68.0× | 0.10 | up 11% | 6.9× | 1.31 | up 78% | 7/9 | Moderate | |
| BVS | Bioventus Inc. | Health Care | $13.32 | down 10.9% | down 2.2% | up 96.8% | 4.4% | 90 | 7/8 | — | — | — | up 14% | — | 1.52 | up 334% | — | Unknown | |
| CADL | Candel Therapeutics, Inc. | Health Care | $8.33 | up 3.7% | down 20.2% | up 49.3% | 6.8% | 74 | 5/8 | $457.3M | — | — | down 65% | 8.8× | 0.89 | — | — | Unknown | |
| CAH | Cardinal Health Inc | Health Care | $250.48 | up 0.4% | up 12.8% | up 32.9% | 2.3% | 79 | 8/8 | $67.9B | 39.6× | 3.27 | — | — | — | — | 6/9 | Elevated | |
| CAI | Caris Life Sciences, Inc. | Health Care | $34.33 | up 7.3% | up 12.1% | up 10.1% | 5.5% | 97 | 8/8 | $9.7B | — | — | down 12% | 16.8× | 0.66 | — | — | Elevated | |
| CAPR | Capricor Therapeutics, Inc. | Health Care | $6.38 | up 7.6% | down 32.6% | up 2.7% | 9.7% | 25 | 1/8 | $366.0M | — | — | down 47% | 1.2× | — | — | — | Low | |
| CBIO | Crescent Biopharma, Inc. | Health Care | $13.48 | up 5.1% | down 7.6% | up 7.8% | 8.1% | 45 | 3/8 | $371.5M | 2413.0× | — | 0% | 1.8× | 0.00 | — | — | Low | |
| CBLL | Ceribell, Inc. | Health Care | $26.58 | down 2.0% | up 9.0% | up 134.8% | 4.8% | 94 | 8/8 | $996.4M | — | — | down 31% | 6.4× | 0.13 | — | 4/9 | Low | |
| CCCC | C4 Therapeutics, Inc. | Health Care | $3.37 | up 10.1% | up 1.2% | up 37.0% | 6.4% | 80 | 5/8 | $326.6M | — | — | down 44% | 1.3× | — | — | — | Elevated | |
| CDNA | Caredx, Inc. | Health Care | $87.41 | up 26.3% | up 34.5% | up 504.1% | 5.6% | 99 | 8/8 | $4.5B | — | — | down 6% | 14.7× | — | up 1026% | — | Elevated | |
| CDRE | Cadre Holdings, Inc. | Health Care | $30.36 | up 1.6% | up 21.4% | down 28.0% | 3.9% | 26 | 1/8 | $1.3B | 29.0× | 2.16 | up 14% | 4.0× | 0.92 | down 12% | 6/9 | Low | |
| CELC | Celcuity Inc. | Health Care | $69.13 | up 5.9% | down 13.1% | down 12.4% | 5.8% | 11 | 0/8 | $3.3B | — | — | down 164% | 33.2× | 1.37 | — | — | Elevated | |
| CERS | Cerus Corp | Health Care | $2.28 | down 2.1% | down 4.2% | up 62.9% | 4.4% | 63 | 3/8 | $438.1M | — | — | down 26% | 6.8× | 1.31 | — | — | Elevated | |
| CGEM | Cullinan Therapeutics, Inc. | Health Care | $15.03 | up 4.6% | down 2.1% | up 98.8% | 6.4% | 80 | 5/8 | $905.5M | — | — | down 44% | 2.2× | — | — | — | Unknown | |
| CGON | Cg Oncology, Inc. | Health Care | $64.68 | up 4.8% | down 8.8% | up 52.3% | 4.4% | 66 | 5/8 | $5.2B | — | — | down 22% | 6.9× | 0.00 | — | — | Low | |
| CHE | Chemed Corp | Health Care | $534.72 | up 4.2% | up 5.9% | up 18.3% | 2.8% | 69 | 7/8 | $20.1B | 75790.9× | — | 0% | 20.5× | — | up 22% | 6/9 | Low | |
| CI | Cigna Group | Health Care | $298.23 | down 2.8% | up 9.7% | up 23.4% | 2.5% | 55 | 6/8 | $78.6B | 13.2× | 0.16 | up 14% | 1.9× | 0.74 | up 10% | 7/9 | Moderate |